Covid 19 Research using Clinical Trials (Home Page)
iNO (inhaled nitric oxide) delivered via the INOpulse Delivery SystemWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
|
Name (Synonyms) |
Correlation |
drug1904 | Prevalence of COVID-19 Wiki | 1.00 |
Correlated MeSH Terms (4)
There is one clinical trial.
Clinical Trials
The search for novel therapies to address the ongoing coronavirus (COVID-19) pandemic is
ongoing. No proven therapies have been identified to prevent progression of the virus.
Preliminary data suggest that inhaled nitric oxide (iNO) could have benefit in preventing
viral progression and reducing reliance on supplemental oxygen and ventilator support.
Expanded access allows for iNO to be delivered via the portable INOpulse delivery system for
the treatment of COVID-19.
NCT04358588 Coronavirus Infection COVID-19 Pneumonia, Viral Drug: iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System
Related HPO nodes (Using clinical trials)